Work

S1600 Comparing the Safety of Risankizumab vs Other Biological Therapies in Older Adults With Crohn’s Disease

Year: 2025

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0001133860.29758.f1

Authors: Anthony Bilotta, Abbas Rupawala

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417166187

Cites:

Cited by:

Related to: